Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pathway to precision: machine learning and bioinformatics in diabetes gene expression studies

T. Aldaghi, A. Chrissan, J. Muzik, M. Rezaei-Tavirani, E. Nazari

. 2026 ; 25 (1) : 3. [pub] 20251217

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc26001537

BACKGROUND: Diabetes mellitus is a metabolic disorder; understanding the pathogenic mechanisms underlying diabetes is crucial. Analyzing biomarkers, supported by machine learning and bioinformatics, is crucial for identifying the molecular causes of diabetes. OBJECTIVE: This study summarizes the current advances in diabetes research, highlighting significant progress in bioinformatics, gene expression analysis, and machine learning. METHODS: The search was conducted in Google Scholar, PubMed, and Scopus using two sets of keywords, including terms like diabetes, biomarkers, bioinformatics, and machine learning. The selection process followed PRISMA guidelines. The inclusion criteria targeted open-access English articles published from 2020 to 2024, resulting in a final selection of 96 articles. RESULTS: The findings were grouped into six categories: data acquisition methods, complications, bioinformatics techniques, machine learning methods, promotion, and evaluation. Microarrays were the most frequent technique for data collection, with 70 occurrences. The most common bioinformatics method was KEGG pathway analysis (84 instances). The most frequently used machine learning techniques were LASSO (43) and PCA (47). Prognostic applications were reported 45 times, while diagnostic applications appeared 51 times. CONCLUSION: Recent studies have highlighted the importance of KEGG pathway analysis and microarray datasets in diabetes research. Newer technologies, such as RNA-seq and single-cell RNA-seq, remain underutilized despite significant advancements in their development. A greater focus on novel biological pathways, the development of biomarkers, and a more comprehensive application of machine learning techniques could all aid in personalized treatment for diabetes. Future research should aim to overcome technological limitations and integrate clinical data with bioinformatics workflows to enhance translational relevance and promote precision medicine.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc26001537
003      
CZ-PrNML
005      
20260122082550.0
007      
ta
008      
260116s2026 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s40200-025-01814-2 $2 doi
035    __
$a (PubMed)41424950
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Aldaghi, Tahmineh $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Pathway to precision: machine learning and bioinformatics in diabetes gene expression studies / $c T. Aldaghi, A. Chrissan, J. Muzik, M. Rezaei-Tavirani, E. Nazari
520    9_
$a BACKGROUND: Diabetes mellitus is a metabolic disorder; understanding the pathogenic mechanisms underlying diabetes is crucial. Analyzing biomarkers, supported by machine learning and bioinformatics, is crucial for identifying the molecular causes of diabetes. OBJECTIVE: This study summarizes the current advances in diabetes research, highlighting significant progress in bioinformatics, gene expression analysis, and machine learning. METHODS: The search was conducted in Google Scholar, PubMed, and Scopus using two sets of keywords, including terms like diabetes, biomarkers, bioinformatics, and machine learning. The selection process followed PRISMA guidelines. The inclusion criteria targeted open-access English articles published from 2020 to 2024, resulting in a final selection of 96 articles. RESULTS: The findings were grouped into six categories: data acquisition methods, complications, bioinformatics techniques, machine learning methods, promotion, and evaluation. Microarrays were the most frequent technique for data collection, with 70 occurrences. The most common bioinformatics method was KEGG pathway analysis (84 instances). The most frequently used machine learning techniques were LASSO (43) and PCA (47). Prognostic applications were reported 45 times, while diagnostic applications appeared 51 times. CONCLUSION: Recent studies have highlighted the importance of KEGG pathway analysis and microarray datasets in diabetes research. Newer technologies, such as RNA-seq and single-cell RNA-seq, remain underutilized despite significant advancements in their development. A greater focus on novel biological pathways, the development of biomarkers, and a more comprehensive application of machine learning techniques could all aid in personalized treatment for diabetes. Future research should aim to overcome technological limitations and integrate clinical data with bioinformatics workflows to enhance translational relevance and promote precision medicine.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Chrissan, Ashley $u Samueli School of Engineering, University of California, Los Angeles, Los Angeles, CA USA
700    1_
$a Muzik, Jan $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
700    1_
$a Rezaei-Tavirani, Mostafa $u Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
700    1_
$a Nazari, Elham $u Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
773    0_
$w MED00217204 $t Journal of diabetes and metabolic disorders $x 2251-6581 $g Roč. 25, č. 1 (2026), s. 3
856    41
$u https://pubmed.ncbi.nlm.nih.gov/41424950 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20260116 $b ABA008
991    __
$a 20260122082535 $b ABA008
999    __
$a ok $b bmc $g 2470197 $s 1267254
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2026 $b 25 $c 1 $d 3 $e 20251217 $i 2251-6581 $m Journal of diabetes and metabolic disorders $n J Diabetes Metab Disord $x MED00217204
LZP    __
$a Pubmed-20260116

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...